Healthcare Finance News February 7, 2025
Hospitals and drugmakers are urging the president to exempt pharmaceuticals and medical goods from his new tariffs on Chinese imports.
The Trump administration’s proposed tariffs on imported goods from Canada and Mexico may currently be on pause, but uncertainty over their potential reinstatement is having a ripple effect across the healthcare and pharmaceutical industries.
An additional 10% tariff on Chinese imports went into effect on Tuesday.
Hospitals and drugmakers are urging the president to exempt pharmaceuticals and medical goods from the new tariffs on Chinese imports.
In a letter to President Trump on Tuesday, the American Hospital Association said, “The U.S. imports many cancer and cardiovascular medications, immunosuppressives, antibiotics and combination antibiotics from China.”
WHY THIS MATTERS
If imposed, these...
Today's Sponsors
Today's Sponsor